SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001477932-17-003734
Filing Date
2017-08-08
Accepted
2017-08-08 16:15:47
Documents
1
Period of Report
2016-08-30

Document Format Files

Seq Description Document Type Size
1 FORM 3 form3.html 3  
1 FORM 3 form3.xml 3 1617
  Complete submission text file 0001477932-17-003734.txt   3161
Mailing Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915
Business Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915 978-921-4125
Innovation Pharmaceuticals Inc. (Issuer) CIK: 0001355250 (see all company filings)

IRS No.: 134303398 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 100 CUMMINGS CENTER, SUITE 151-B BEVERLY MA 01915
Business Address
Harness Jane A. (Reporting) CIK: 0001702800 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37357 | Film No.: 171014925